Keosys-Blog-Graphic-1

The Keosys Blog

Expert insights into medical imaging in clinical trials.
Keosys
3 Things your Imaging CRO Needs in 2023
Imaging CROs provide critical expertise that can help to optimize clinical..
Keosys
Interview: 2022 in Review with Oana Popa-Nita
2022 Year in Review 2022 is coming to a close, and it’s a great time to reflect..
Keosys
The Best Keosys Blogs of 2022
Recap: Top blog posts of 2022 It’s been a great year for Keosys, the..
Keosys
Prostate Cancer Resource Page
Prostate Cancer Resource Page Prostate cancer is the second most common cancer..
Keosys
Evaluating Tumor Response
This is an excerpt from our free eBook, “Prostate Cancer and Imaging in..
Keosys
Interview: An Immunotherapeutic Drug Development Expert Discusses Future of Cancer Management
William Le brings nearly 20 years of experience in drug development in oncology..
Keosys
Prostate Cancer and Imaging
This is an excerpt from our free eBook, “Prostate Cancer and Imaging in..
Keosys
HU, SUV, and More: Different Metrics in The World of Imaging
Medical imaging is an essential tool in healthcare for diagnosis, treatment,..
Keosys
Prostate Cancer Working Group 3: Imaging Assessments Infographic
Prostate Cancer Working Group 3 (PCWG3) is an international working group of..
Keosys
Interview: A Clinical R&D Expert Talks About the Future of Radiopharmaceuticals
With a background in clinical research and development, UK-trained physician..
Keosys
Why are so many imaging queries sent to your site and how can you avoid them?
Why are so many imaging queries sent to your site and how can you avoid them?..
Keosys
Heptocellular Carcinoma (HCC) Resource Page
Hepatocellular Carcinoma (HCC) is the most common cancer of the liver and the..

More Posts

New call-to-action